Acute Exacerbations Treated With BenRAlizumab (The ABRA Study)
Clinical trial NCT04098718 · UNKNOWN
Trial details
- NCT number
- NCT04098718
- Sponsor
- University of Oxford
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2024-02-19
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.